Avadel Pharmaceuticals Reports First Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Avadel Pharma (AVDL) Reports Q1 EPS of $0.26, Offers Guidance
May 9, 2017 7:39 AM EDTAvadel Pharma (NASDAQ: AVDL) reported Q1 EPS of $0.26, versus $0.04 reported last year. Revenue for the quarter came in at $52.5 million, versus $36.2 million reported last year.
2017 Guidance
The Company is increasing its full year adjusted EPS guidance to a range of $0.30 to $0.45 per... More
